Skip to content

AcrySof™ IQ PanOptix™ Toric UV IOL TFAT60 (REF TFAT60.080)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix Toric UV IOL (120)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652420051), received between Jul 6, 2022 and Jul 6, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Malposition of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Malposition of Device1

Patient problems

  • Blurred Vision1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 6, 2022Malposition of Device; Malposition of Device

    A NON HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING THE INTRAOCULAR LENS IMPLANT PROCEDURE, PATIENTS VISION BECAME VERY BLURRED WHICH WAS ATTRIBUTED TO ROTATION OF THE IOL. THE PATIENT HAD GONE FOR SECOND SURGERY TO ROTATE THE IOL, BUT BLURRED VISION BECAME WORSE. ADDITIONAL INFORMATION RECEIVED AND STATED THAT VISUAL SYMPTOMS ARE UNRELATED TO IOL OR SURGERY. THE PATIENT HAS BEEN DIAGNOSED POSSIBLY WITH MENINGIOMA.

    Patient problems: Blurred Vision

    MAUDE report 14926892 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page